ClinicalTrials.Veeva

Menu

Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung

T

Tel Aviv Sourasky Medical Center

Status

Completed

Conditions

Occupational Lung Diseases
Asthma
Chronic Obstructive Pulmonary Disease
Interstitial Lung Diseases

Treatments

Other: no generic names

Study type

Observational

Funder types

Other

Identifiers

NCT00511290
TASMC-07-LF-07316-CTIL

Details and patient eligibility

About

In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis.

The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.

Sex

All

Ages

7 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages 7-80

Exclusion criteria

  • FEV1 < 75% predicted pO2 < 75

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems